Results 21 to 30 of about 26,508 (157)

Design and characteristics of the prophylactic intra‐operative ventricular arrhythmia ablation in high‐risk LVAD candidates (PIVATAL) trial

Annals of Noninvasive Electrocardiology, 2023
Background The use of a Left Ventricular Assist Device (LVAD) in patients with advanced heart failure refractory to optimal medical management has progressed steadily over the past two decades. Data have demonstrated reduced LVAD efficacy, worse clinical
David T. Huang, Igor Gosev, Katherine L. Wood, Hima Vidula, William Stevenson, Frank Marchlinski, Gregory Supple, Sandip K. Zalawadiya, J. Peter Weiss, Roderick Tung, Wendy S. Tzou, Joshua D. Moss, Krishna Kancharla, Sunit‐Preet Chaudhry, Parin J. Patel, Arfaat M. Khan, Claudio Schuger, Guy Rozen, Michael S. Kiernan, Gregory S. Couper, Marzia Leacche, Ezequiel J. Molina, Anand D. Shah, Michael Lloyd, Jakub Sroubek, Edward Soltesz, Kalyanam Shivkumar, Casey White, Sinan Tankut, Brent A. Johnson, Scott McNitt, Valentina Kutyifa, Wojciech Zareba, Ilan Goldenberg   +33 more
doaj   +1 more source

Lawn Mower Versus Left Ventricular Assist Device

JACC: Case Reports, 2020
A 77-year-old man with history of ischemic cardiomyopathy and left ventricular assist device (LVAD) presented with abdominal pain after a lawn mower accident.
Vishal N. Rao, MD, MPH, Marat Fudim, MD, MHS, Andrew Griffin, MD, Jennifer A. Rymer, MD, MBA, W. Schuyler Jones, MD, Lynne M.H. Koweek, MD, Tony P. Smith, MD, Daniele Marin, MD, Adam D. DeVore, MD, MHS   +8 more
doaj   +1 more source

Experience with left ventricular assist device usage in the treatment of end-stage heart failure [PDF]

Кардіохірургія та інтервенційна кардіологія, 2017
Heart failure potentially developing in most of heart diseases is a progressive process associated with high morbidity and mortality. Almost 3/4 of patients die within five years after first hospitalization because of heart failure.
B.M. Todurov, G.I. Kovtun, I.M. Kuzmich, M.V. Goncharenko, A.M. Druzhyna, A.O. Shpachuk, O.M. Postupalsky, S.O. Sheludko, S.M. Sudakevych, O.V. Stanyshevskyi, A.Yu. Melnyk   +10 more
doaj  

Modalities of Left Ventricle Decompression during VA-ECMO Therapy

Membranes, 2021
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used to sustain circulatory and respiratory support in patients with severe cardiogenic shock or refractory cardiac arrest.
Juan Pablo Ricarte Bratti, Yiorgos Alexandros Cavayas, Pierre Emmanuel Noly, Karim Serri, Yoan Lamarche   +4 more
doaj   +1 more source

Use of Right Ventricular Assist Device Post-Left Ventricular Assist Device Placement

Hearts
Right heart failure (RHF) is a common manifestation after left ventricular assist device (LVAD) placement and is associated with a high mortality rate. Historically, RV failure requiring an RVAD at the time of LVAD implantation has been associated with ...
Shannon Parness, Tori E. Hester, Harish Pandyaram, Panagiotis Tasoudis, Aurelie E. Merlo   +4 more
doaj   +1 more source

Cardiovascular prevention and rehabilitation for patients with ventricular assist device From exercise therapy to long-term therapy Part I: exercise therapy

Monaldi Archives for Chest Disease, 2015
In the present context of an aging population, limited donor heart availability, improved reliability of mechanical cardiac support and improved patient outcomes, ventricular assist device (VAD) options to support end-stage heart failure patients are ...
Ugo Corrà, Massimo Pistono, Alessandro Mezzani, Marco Gnemmi, Franco Tarro Genta, Roberto Caruso, Pantaleo Giannuzzi   +6 more
doaj   +1 more source

Intravenous administration of umbilical cord lining stem cells in left ventricular assist device recpieint: Rational and design of the uSTOP LVAD BLEED pilot study

American Heart Journal Plus, 2022
Background: Left ventricular assist device (LVAD) implantation provides a robust survival advantage, however despite improvements in mortality, the adverse event burden of durable mechanical circulatory support remains high.
Mustafa M. Ahmed, Lauren E. Meece, Eileen M. Handberg, Carl J. Pepine   +3 more
doaj   +1 more source

Endocarditis in left ventricular assist device

Intractable & Rare Diseases Research, 2016
Heart failure is one of the leading causes of death in developed nations. End stage heart failure often requires cardiac transplantation for survival. The left ventricular assist device (LVAD) has been one of the biggest evolvements in heart failure management often serving as bridge to transplant or destination therapy in advanced heart failure.
Thyagarajan, Braghadheeswar, Kumar, Monisha Priyadarshini, Sikachi, Rutuja R, Agrawal, Abhinav   +3 more
openaire   +3 more sources

Modification of a Ventricular Assistance Device for a Hemiplegic Left Ventricular Assist Device Patient

ASAIO Journal, 2019
Neurologic events occur in up to 18% of patients with continuous-flow left ventricular assist devices (LVAD) and is associated with significant morbidity and mortality. The current form of the LVAD equipment is not suited to serve patients who are impaired by a stroke.
Muslem, Rahat, Yalçin, Yunus, Caliskan, Kadir, van der Heiden, CW, van Rhijn, JHC, Bogers, Ad, Manintveld, Olivier   +6 more
openaire   +4 more sources

Biosensors with left ventricular assist devices

Heart Failure Reviews
AbstractHeart failure imposes a significant global health burden, standing as a primary contributor to mortality. Various indicators and physiological shifts within the body may hint at distinct cardiac conditions. Specific biosensors have the capability to identify these changes.
Mahmoud Abbassy, Muhammad Zain Ali, Riya Manas Sharma, Yohan Porus Irani, Adil Dahlan, Maimoona Azhar, Nadeem Aslam, Babar Hasan, Aamir Hameed   +8 more
openaire   +2 more sources